title: First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.
authors.forename: L S
authors.initials: LS
authors.lastname: Pilowsky
authors.forename: R A
authors.initials: RA
authors.lastname: Bressan
authors.forename: J M
authors.initials: JM
authors.lastname: Stone
authors.forename: K
authors.initials: K
authors.lastname: Erlandsson
authors.forename: R S
authors.initials: RS
authors.lastname: Mulligan
authors.forename: J H
authors.initials: JH
authors.lastname: Krystal
authors.forename: P J
authors.initials: PJ
authors.lastname: Ell
mesh_terms: D000704:Analysis of Variance; D014150:Antipsychotic Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D003024:Clozapine / Q000627:therapeutic use; D007839:Functional Laterality / Q000502:physiology; D020022:Genetic Predisposition to Disease; D006146:Guanidines / Q000378:metabolism; D006624:Hippocampus / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate / Q000235:genetics* / Q000378:metabolism*; D012016:Reference Values; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D014018:Tissue Distribution; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D014150:Antipsychotic Agents; C417904:CNS 1261; D006146:Guanidines; D016194:Receptors, N-Methyl-D-Aspartate; D003024:Clozapine